Life sciences briefing: Monday, Nov. 26, 2007
Featured companies: Biospace Med, Carbylan BioSurgery, GVK BioSciences, IntraSafe Medical, InViragen, Medingo, ParadigmHealth, Precimed, SV Life Sciences
UPDATED: Expanded items on Carbylan, Medingo, and GVK Biosciences.
Carbylan raises $20M for arthritis, sinusitis drug implants — Palo Alto, Calif.-based Carbylan BioSurgery, a medical-device maker focused on polymer-based drug-delivery technologies, raised $20 million in a second funding round. Investors included Vivo Ventures, Alta Partners and InterWest Partners.
Carbylan is developing a biomaterial-based drug-delivery system in which drug-impregnated polymers of hyaluronic acid… Continue Reading